Wendy Chu

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Mondal, Dinesh et al.

Ingår i Clinical Pharmacology and Therapeutics, s. 437-446, 2026

• DOI för Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
• Ladda ner fulltext (pdf) av Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Pandey, Krishna et al.

Ingår i International Journal of Antimicrobial Agents, 2026

• DOI för Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis
• Ladda ner fulltext (pdf) av Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Chu, Wan-Yu; Fahal, Ahmed H; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak et al.

Ingår i Journal of Infectious Diseases, 2025

• DOI för Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma
• Ladda ner fulltext (pdf) av Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Chu, Wan-Yu; Schouten, Wietse M.; Mavoko, Hypolite Muhindo; Tshiongo, Japhet Kabalu et al.

Ingår i Clinical Pharmacokinetics, s. 1855-1867, 2025

• DOI för Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study
• Ladda ner fulltext (pdf) av Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Dorlo, Thomas P. C.; Chu, Wan-Yu

Ingår i Journal of Antimicrobial Chemotherapy, s. 1162-1164, 2025

• DOI för Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Mondal, Dinesh et al.

Ingår i Clinical Pharmacology and Therapeutics, s. 437-446, 2026

• DOI för Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
• Ladda ner fulltext (pdf) av Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Chu, Wan-Yu; Singh, Om Prakash; Sundar, Shyam; Pandey, Krishna et al.

Ingår i International Journal of Antimicrobial Agents, 2026

• DOI för Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis
• Ladda ner fulltext (pdf) av Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Chu, Wan-Yu; Fahal, Ahmed H; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak et al.

Ingår i Journal of Infectious Diseases, 2025

• DOI för Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma
• Ladda ner fulltext (pdf) av Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Chu, Wan-Yu; Schouten, Wietse M.; Mavoko, Hypolite Muhindo; Tshiongo, Japhet Kabalu et al.

Ingår i Clinical Pharmacokinetics, s. 1855-1867, 2025

• DOI för Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study
• Ladda ner fulltext (pdf) av Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Dorlo, Thomas P. C.; Chu, Wan-Yu

Ingår i Journal of Antimicrobial Chemotherapy, s. 1162-1164, 2025

• DOI för Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia: authors' response

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia

Palic, Semra; Chu, Wan-Yu; Sundar, Shyam; Mondal, Dinesh et al.

Ingår i Journal of Antimicrobial Chemotherapy, s. 1547-1554, 2024

• DOI för Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
• Ladda ner fulltext (pdf) av Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

Chu, Wan-Yu; Verrest, Luka; Younis, Brima M; Musa, Ahmed M et al.

Ingår i Journal of Infectious Diseases, 2024

• DOI för Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa
• Ladda ner fulltext (pdf) av Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Fahal, Ahmed H.; Ahmed, Eiman Siddig; Bakhiet, Sahar Mubarak; Bakhiet, Osama Elhadi et al.

Ingår i The Lancet - Infectious diseases, s. 1254-1265, 2024

• DOI för Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease

Chu, Wan-Yu; Nijman, Maaike; Stegeman, Raymond; Breur, Johannes M. P. J. et al.

Ingår i Clinical Pharmacokinetics, s. 1205-1220, 2024

• DOI för Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease
• Ladda ner fulltext (pdf) av Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease

Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model

Verrest, Luka; Monnerat, Severine; Musa, Ahmed M.; Mbui, Jane et al.

Ingår i PLoS Neglected Tropical Diseases, 2024

• DOI för Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model
• Ladda ner fulltext (pdf) av Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis

Verrest, Luka; Roseboom, Ignace C.; Wasunna, Monique; Mbui, Jane et al.

Ingår i Journal of Antimicrobial Chemotherapy, s. 2702-2714, 2023

• DOI för Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
• Ladda ner fulltext (pdf) av Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis

Comment on "Dosing implications for liposomal amphotericin B in pregnancy"

Chu, Wan-Yu; Dorlo, Thomas P. C.

Ingår i Pharmacotherapy, s. 991-991, 2023

• DOI för Comment on "Dosing implications for liposomal amphotericin B in pregnancy"